Metabical is a prescription drug produced by Cambridge Sciences Pharmaceuticals (CSP) for weight loss‚ which was the first and only prescription drug to obtain FDA approval. The drug was developed to help aid people in the overweight segment to lose 10 to 30 pounds. Barbara Printup is the marketing director in charge of selecting a price for the new prescription drug. In a study CSP did with Metabical‚ people with a body mass index (BMI) of 28 to 30 had an average weight loss of 26 pounds over a
Premium Obesity Marketing
1. How does Metabical compare to current weight-loss options? Answer: Metabical is revolutionary product and forecasted to be the first FDA approved prescriptive drug for overweight individuals with weight-loss goals. The previous prescriptive drugs have a negative side effects that out weighed its positives. Metabical‚ on the other hand‚ did not display as many negative effects in its trail runs and thus was being strongly endorsed by the medical community. The current weight-loss drugs can be
Premium Obesity Weight loss Cancer
Mai Nguyen New Product Planning Professor Patton 3/5/14 Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug Case 1. How does Metabical compare to current weight-loss options? There are only several other weight-loss options in the market competing with Metabical. The first is prescription drugs. These are prescribed for use only by obese and severely obese individuals. This meant that only individuals with BMI of over 30 who were prescribed weight-loss drugs
Premium Obesity Medical prescription Drugs
The Global Positioning System With the proliferation of satellite-based defense systems and their continuing presence in the media it makes us more aware of our national defense. The United States is large‚ economically strong and a sometimes tumultuous presence in the global community. Although we may feel secure because of our superior technology and defense capabilities‚ our size and position in world affairs can make us a target for some countries. We can no longer be concerned with just our
Premium Global Positioning System Navigation
Metabical (Case study) Case Facts • Metabical is a prescription drug produced by Cambridge Sciences Pharmaceuticals (CSP) for weight loss. • It was the first and only prescription drug to obtain FDA approval for weight loss (overweight category) drug. • The company had conducted an elaborate market research program for identifying the target segment and positioning the product. • Competitors: FDA approved OTC drug Alli. • Marketing strategy: – DTC advertising- celebrity endorser‚ TV‚ radio‚
Premium Obesity Food and Drug Administration Marketing
• What is the decision making process for Metabical? ◦ Who is involved? ◦ What role do they play? ◦ What are the stages in the process? In the launch of Metabical for the US market‚ several marketing decisions need to be made to bring a viable product into the market to maximize market penetration and gross margins over the PLC and to best serve the needs of the customers The players are • Health Care Professionals ◦ Will prescribe Metabical to their patients ◦ Can influence Insurance Companies
Premium Marketing
The Technological Advancements and Trade Offs of The Global Positioning System and Subsystems Table of Contents I. Background and Brief Description – a. Sputnik 1957 (Science that Drove the Technology) b. Applications of the Technology II. History of the Technology – a. Satellites to Soup b. The Drivers for Demand III. Political and Legal Influences – a. Government Interventions – b. Jessica Lunsford Act: Lifetime tracking by GPS IV. Economic Questions and Considerations
Premium Global Positioning System
272593 BUS 474 A 02/14/2011 Metabical After spending millions of dollars for ten years in research and development‚ Metabical was finally able to receive FDA approval‚ making it the first and only drug to receive FDA approval to meet the needs of customers who have been trying to lose weight. Like with any other new product‚ numerous issues need to be considered before Metabical is actually introduced in the market. Decisions about pricing‚ packaging and demand forecast of the product are key
Premium Obesity Pharmacology
[pic] Business Case Metabical Version 1.0 ● October 21th‚ 2010 [pic] Work Group Metabical – Business Case |VERSION: 1 |REVISION DATE: 10/21/2010 | |Team Members | |Eduardo Lins |[Email] |[Telephone]
Premium Obesity
B Problem Statement Barbara Printup must determine the packaging for Metabical that will best capture the accurately forecasted demand of the target market. With many substitutes for weight loss in a variety of packages and price points‚ it will be important to create a package that can be priced in a way to both drive sales and continued use of the 12-week drug. Printup must also develop a pricing model to align with the packaging and the price expectations of the target market. Since this is
Premium Price Marketing Price point